Y010-1363 Screening compound: 3-phenyl-2-[(phenylcarbamoyl)methyl]butanoic acid

Y010-1363 Screening compound: 3-phenyl-2-[(phenylcarbamoyl)methyl]butanoic acid
Y010-1363 Screening compound: 3-phenyl-2-[(phenylcarbamoyl)methyl]butanoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound Y010-1363
3-phenyl-2-[(phenylcarbamoyl)methyl]butanoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y010-1363

Molecular Formula

C18H19NO3 (C18 H19 NO3)

Compound Name

3-phenyl-2-[(phenylcarbamoyl)methyl]butanoic acid

IUPAC name

3-phenyl-2-[(phenylcarbamoyl)methyl]butanoic acid

SMILES

CC(C(CC(Nc1ccccc1)=O)C(O)=O)c1ccccc1

InChI

InChI=1S/C18H19NO3/c1-13(14-8-4-2-5-9-14)16(18(21)22)12-17(20)19-15-10-6-3-7-11-15/h2-11,13,16H,12H2,1H3,(H,19,20)(H,21,22)

InChI Key

BDMDXLRFUPFFHD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01117449

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

297.35

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

2.598

Distribution Coefficient, logD

-0.026

Water Solubility, LogSw

-3.10

Polar Surface Area

51.524

Acid Dissociation Constant (pKa)

4.78

Base Dissociation Constant (pKb)

0.73

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

22.20

Y010-1363 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

CORONAVIRUS Library (20774 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with Y010-1363 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y010-1363?
Check Price and Availability of Y010-1363, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y010-1363 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y010-1363
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y010-1363
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y010-1363 available by request